Full Text | PDF

Share on facebook Share on tweeters Share on linkedin Share on googleplus

Theranostics 2023; 13(7):2257-2258. doi:10.7150/thno.84874 This issue Cite

Erratum

Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas: Erratum

Hui-Min Lei1,2*, Ke-Ren Zhang1*, Cong Hui Wang1*, Yang Wang1, Guang-Lei Zhuang3, Li-Ming Lu4, Jian Zhang5, Ying Shen1,2✉, Hong-Zhuan Chen1,2✉, Liang Zhu1,2✉

1. Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
2. Shanghai Collaborative Innovation Center for Translational Medicine, Shanghai, 200025, China
3. State Key Laboratory of Oncogenes and Related Genes, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
4. Central laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China; Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
5. Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao-Tong University School of Medicine, Shanghai 200025, China.
* These authors contributed equally to this study.

✉ Corresponding authors: jyzhuledu.cn (L. Z.), yaoliedu.cn (H. Z. C), yshen0510edu.cn (Y. S.)

Citation:
Lei HM, Zhang KR, Wang CH, Wang Y, Zhuang GL, Lu LM, Zhang J, Shen Y, Chen HZ, Zhu L. Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas: Erratum. Theranostics 2023; 13(7):2257-2258. doi:10.7150/thno.84874. https://www.thno.org/v13p2257.htm
Other styles

File import instruction

Corrected-article in Theranostics, Volume 9, 7122

Citation styles

APA
Lei, H.M., Zhang, K.R., Wang, C.H., Wang, Y., Zhuang, G.L., Lu, L.M., Zhang, J., Shen, Y., Chen, H.Z., Zhu, L. (2023). Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas: Erratum. Theranostics, 13(7), 2257-2258. https://doi.org/10.7150/thno.84874.

ACS
Lei, H.M.; Zhang, K.R.; Wang, C.H.; Wang, Y.; Zhuang, G.L.; Lu, L.M.; Zhang, J.; Shen, Y.; Chen, H.Z.; Zhu, L. Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas: Erratum. Theranostics 2023, 13 (7), 2257-2258. DOI: 10.7150/thno.84874.

NLM
Lei HM, Zhang KR, Wang CH, Wang Y, Zhuang GL, Lu LM, Zhang J, Shen Y, Chen HZ, Zhu L. Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas: Erratum. Theranostics 2023; 13(7):2257-2258. doi:10.7150/thno.84874. https://www.thno.org/v13p2257.htm

CSE
Lei HM, Zhang KR, Wang CH, Wang Y, Zhuang GL, Lu LM, Zhang J, Shen Y, Chen HZ, Zhu L. 2023. Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas: Erratum. Theranostics. 13(7):2257-2258.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2025 Ivyspring International Publisher. Terms of use